Metastatic Breast Cancer A rational approach to selecting therapy for patients with metastatic breast cancer: –For patients with bone metastases: monthly administration of Pamidronate or Zolendronate (regardless of ER/PR/her-2 status) –For patients with ER and/or PR positive breast cancer, with low burden of metastases and slow pace of disease: start with hormonal agents.
{}